Eliška Táborská, Ph.D.

Eliška Táborská, Ph.D. has a diverse work experience in the field of biology and biotechnology. Eliška is currently working as a Biologist with AI at BioXcel Therapeutics, Inc. since 2022. Previously, they worked as a Scientist at SOTIO a.s. from 2020 to 2022, where they characterized the functional orientation of the immune environment in head and neck and cervical cancers. Eliška also tested trends from patient data in mouse models and in vitro experiments to investigate potential immunotherapies.

Eliška has also worked as a Consultant in biotechnology at BioXcel Therapeutics, Inc. from 2021 to 2022. Before that, they were a PhD student at the Institute of Molecular Genetics from 2013 to 2020, where they focused on RNA interference in mouse oocytes and somatic cells. Eliška designed and analyzed genetically modified mouse models and mouse embryonic stem cell lines with alterations in RNAi and piRNA pathways.

Additionally, Eliška gained experience as an intern at MRC Centre for Regenerative Medicine, Donal O'Carroll laboratory in 2017, where they learned to prepare libraries for polyA tail sequencing. Eliška also interned at The Hebrew University of Jerusalem, Yehu Moran laboratory in 2017 as part of a collaborative project.

Furthermore, Eliška worked as a Master Thesis Student at the Institute of Animal Physiology and Genetics, Academy of the Sciences of the Czech Republic from 2010 to 2013. Eliška'sthesis focused on the generation of porcine induced pluripotent stem cells as an in vitro model of Huntington's disease.

Eliška Táborská, Ph.D., began their education at Charles University, where they obtained a Bachelor's degree in Biology from 2008 to 2011. Eliška continued their studies at the same institution, earning a Master's degree in Developmental and Cell Biology between 2011 and 2013. Eliška then pursued further academic achievements at Charles University, completing their Doctor of Philosophy (Ph.D.) in Developmental and Cell Biology from 2013 to 2021.